Across TCGA pan-cancer cohorts, LINC02575 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC02575’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC02575 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02575 is over-expressed in tumor, although a few such as LUAD and BRCA show the opposite, repressed pattern.
STAD, LUAD, and HNSC are the cancer types where LINC02575 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02575 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.